Family and Couple Therapy

Subjective:
Chief Complaint:
Persistent low mood, decreased energy, irritability, and difficulty with focus and concentration.

History of Present Illness:
Rebecca presents for a follow-up visit to address ongoing symptoms of low mood, decreased energy, irritability, anxiety, and difficulty with focus and concentration. She reports that her mood remains persistently low, and her energy levels are significantly diminished, which has impacted her ability to engage in daily activities. She describes feeling irritable, though she notes that this has not worsened since her last visit. Her anxiety levels remain elevated, and she continues to struggle with maintaining focus and concentration, though she is making efforts to improve in this area. Rebecca reports that her sleep has shown some improvement, though it is not yet optimal, and her appetite remains stable. She currently weighs 132 pounds. She denies experiencing any side effects from her medications. However, she acknowledges a lack of motivation to engage in activities, which has further compounded her feelings of low mood and energy. Rebecca has been taking amitriptyline 15 milligrams once daily at bedtime and buspirone 7.5 milligrams twice daily as prescribed. She has been informed that the medications may take four to six weeks to show significant improvement, and she has been advised to remain consistent with her medication regimen. During the visit, the decision was made to increase the dosage of amitriptyline to 30 milligrams once daily at bedtime and buspirone to 10 milligrams twice daily to better address her symptoms. Rebecca has been encouraged to incorporate daily walks of 30 minutes and deep breathing exercises into her routine to help improve her mood, anxiety, appetite, and sleep. She has also been advised to practice positive affirmations to foster a more optimistic outlook. Rebecca has an upcoming therapy appointment on the 15th, which she has scheduled based on a list of therapists provided during her last visit. She has been informed that the combination of therapy and medication is likely to yield the best outcomes. Additionally, she has been advised to explore her eligibility for the Family and Medical Leave Act (FMLA) and disability benefits through her workplace, as these may provide financial support during her recovery. She has been instructed to contact her employer to determine her entitlements and to provide any necessary forms for completion. Rebecca denies smoking cigarettes, using marijuana, or consuming alcohol. She has been advised to remain hydrated by drinking plenty of water. She denies experiencing any suicidal or homicidal ideation, intent, or plan. Rebecca has been scheduled for a follow-up visit in two weeks on the 23rd to monitor her progress and adjust her treatment plan as needed.

Social History:
Rebecca is actively working on her mental health and has scheduled a therapy appointment for the 15th. She has been encouraged to incorporate daily walks and deep breathing exercises into her routine to support her recovery. She is exploring her eligibility for FMLA and disability benefits through her workplace to address financial concerns during her treatment.

The Review of Systems:
Rebecca reports persistent low mood, decreased energy, irritability, elevated anxiety levels, and difficulty with focus and concentration. She notes some improvement in her sleep but states that it is not yet optimal. Her appetite remains stable, and she currently weighs 132 pounds. She denies experiencing any side effects from her medications.

Allergies:
No known drug allergies reported.

Current Medications:
Rebecca is currently taking amitriptyline 15 milligrams once daily at bedtime and buspirone 7.5 milligrams twice daily. She has been adherent to her medication regimen and denies experiencing any side effects. The dosages have been adjusted to amitriptyline 30 milligrams once daily at bedtime and buspirone 10 milligrams twice daily to better address her symptoms.

Past Surgical History:
Not mentioned

Session Focus: The session primarily focused on addressing Rebecca's ongoing depressive symptoms, including low mood, reduced energy levels, irritability, and anxiety. The discussion also included her adherence to prescribed medications, her progress with therapy, and lifestyle modifications such as physical activity and relaxation techniques. Additionally, the session explored her eligibility for Family and Medical Leave Act (FMLA) benefits and disability claims to support her during this period.

Substance Use History:
Rebecca denies smoking cigarettes, using marijuana, or consuming alcohol.

Objective:
Physical Examination:
Not assessed

Vital Signs:
Weight: 132 pounds. Other vital signs were not assessed during this session.

Mental Status Examination (MSE):
Appearance: Well-groomed and appropriately dressed.
Behavior: Cooperative and engaged during the session.
Speech: Normal in rate and volume.
Mood: Depressed as stated by the patient.
Affect: Congruent with her stated mood.
Thought Process: Logical and coherent.
Thought Content: No suicidal ideation, homicidal ideation, or delusions reported.
Perception: No hallucinations noted.
Cognition: Alert and oriented to person, place, time, and situation.
Insight: Intact.
Judgment: Fair.

Other Objective Data: No additional clinical measurements or external reports were provided during this session.

Mental Status Examination:
Rebecca appears alert and oriented to person, place, and time. Her appearance is neat and appropriate for the setting. She is cooperative and engages appropriately during the session. Her mood is described as low, and her affect is congruent with her mood. Her speech is normal in rate, rhythm, and volume. Thought processes are logical and goal-directed, with no evidence of delusions or hallucinations. Insight and judgment are intact. There are no observed abnormalities in perception or cognition. Additional details: Her eye contact is appropriate, and she demonstrates a willingness to engage in the therapeutic process. Her memory appears intact, and she is able to recall recent and past events accurately. Her attention and concentration are adequate for the session.

Assessment:
Differential Diagnosis:
• Major Depressive Disorder (F33.1): Rebecca's persistent low mood, decreased energy, irritability, and difficulty with focus and concentration are consistent with this diagnosis.
• Generalized Anxiety Disorder (F41.1): Elevated anxiety levels and associated symptoms such as difficulty concentrating and irritability support this diagnosis.
• Adjustment Disorder with Depressed Mood (F43.21): The possibility of situational stressors contributing to her symptoms should be considered.

Problem:
Rebecca presents with persistent depressive symptoms characterized by low mood, reduced energy levels, irritability, and anxiety. She reports difficulty with focus and concentration, as well as low motivation to engage in daily activities. Her sleep and appetite are reportedly affected, though specific details were not elaborated upon. She is currently prescribed amitriptyline 15 mg once daily at bedtime and buspirone 7.5 mg twice daily. She has been adherent to her medication regimen but has not yet experienced significant improvement, as the medications require four to six weeks for full efficacy. She denies experiencing any side effects from the medications. Additionally, she has been provided with a list of therapists and has scheduled an appointment for therapy on the 15th. Lifestyle modifications, including daily walks and deep breathing exercises, were discussed but have not yet been implemented. The session also addressed her potential eligibility for FMLA benefits and disability claims to provide financial and occupational support during her treatment.

Assessment Conclusion: Rebecca is experiencing ongoing depressive symptoms, including low mood, reduced energy, irritability, and anxiety, which are impacting her daily functioning and quality of life. Her adherence to medication and engagement with therapy are positive indicators for her prognosis. However, her lack of motivation and difficulty implementing lifestyle changes suggest the need for continued support and encouragement.

Intervention: The session included psychoeducation on the expected timeline for medication efficacy and the importance of adherence. The dosages of her medications were adjusted to amitriptyline 30 mg once daily at bedtime and buspirone 10 mg twice daily. She was encouraged to engage in daily physical activity, relaxation techniques, and positive affirmations to complement her pharmacological treatment. The importance of therapy was emphasized, and her upcoming appointment on the 15th was acknowledged as a critical step in her treatment plan.

Engagement and Progress: Rebecca demonstrated a willingness to engage in her treatment plan, as evidenced by her adherence to medications and scheduling of a therapy appointment. While she has not yet implemented lifestyle changes, her openness to discussing these strategies indicates potential for progress. Her insight into her condition and motivation for therapy are promising, though her low energy and mood may pose challenges to sustained engagement. Continued monitoring and support will be essential to her recovery.

Impression:
Rebecca's symptoms are consistent with a diagnosis of Major Depressive Disorder (F33.1) and Generalized Anxiety Disorder (F41.1). Her symptoms, including low mood, decreased energy, irritability, and difficulty with focus and concentration, have a significant impact on her daily functioning. The absence of side effects from her medications and her adherence to the prescribed regimen are positive indicators for treatment progress. The planned increase in medication dosages and the incorporation of therapy are expected to yield further improvements.

Safety Assessment:
Rebecca denies any current suicidal or homicidal ideation, intent, or plan. There are no immediate safety concerns at this time.

Plan:
• Sleep and appetite patterns will be revisited in future sessions. Progress with implementing lifestyle changes will also be addressed.
• The next session is scheduled for April 23, 2025, at a mutually agreed time.
• Rebecca is encouraged to begin daily 30-minute walks, practice deep breathing exercises, and engage in positive affirmations. She is advised to explore eligibility for FMLA benefits and disability claims. She is instructed to communicate with her therapist regarding any forms requiring completion by her psychiatrist.
• The next session will focus on evaluating her response to adjusted medication dosages, progress with therapy, and implementation of lifestyle changes.

Progress and Outcomes:
Rebecca has shown some improvement in her sleep and has been adherent to her medication regimen. She has scheduled a therapy appointment and is actively engaging in her treatment plan. The decision to increase her medication dosages and incorporate lifestyle modifications, such as daily walks and deep breathing exercises, is expected to further support her recovery. A follow-up visit has been scheduled in two weeks to monitor her progress and make any necessary adjustments to her treatment plan.

Extra:
Other Necessary Information: Rebecca was advised to remain consistent with her medication regimen and to drink plenty of water. She was also reminded to reach out if she experiences any concerns or side effects from her medications. The doctor provided a fax number (xxx-xxxx) for any forms that may need to be completed and emphasized the importance of open communication between Rebecca, her therapist, and the psychiatrist to ensure a coordinated approach to her care.